Education
About Us
Working with TipRanks
Follow Us
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ 0.00 | $ -12.57M | $ -4.68M | $ -3.86M | $ -943.93K |
| EBITDA | $ 0.00 | $ -16.48M | $ -4.64M | $ -3.80M | $ -755.00K |
| Net Income | $ 11.91M | $ -16.44M | $ -4.94M | $ -3.21M | $ -755.22K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.99M | $ 1.19M | $ 4.59M | $ 8.26M | $ 38.94K |
| Total Assets | $ 7.21M | $ 2.86M | $ 5.26M | $ 9.33M | $ 115.41M |
| Total Debt | $ 468.00K | $ 4.49M | $ 171.00K | $ 271.00K | $ 0.00 |
| Net Debt | $ -5.52M | $ 3.30M | $ -4.42M | $ -7.99M | $ -38.94K |
| Total Liabilities | $ 4.61M | $ 6.85M | $ 17.31M | $ 16.41M | $ 508.92K |
| Stockholders' Equity | $ 2.60M | $ -3.99M | $ -15.48M | $ -10.66M | $ 114.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.83M | $ -8.42M | $ -4.54M | $ -3.38M | $ -1.41M |
| Operating Cash Flow | $ -10.82M | $ -8.40M | $ -4.53M | $ -3.33M | $ -1.41M |
| Investing Cash Flow | $ -14.00K | $ -22.00K | $ 573.00K | $ -524.00K | $ 0.00 |
| Financing Cash Flow | $ 15.64M | $ 5.10M | $ 522.00K | $ 2.75M | $ 116.40M |